NuovoMediT PenTirzepatide 40mg — Penna di Ricerca Metabolica
or 3 × 83,00 € interest-free
FIDATO DAI RICERCATORI
40mg Prefilled Format
Complete dose-escalation protocol in a single, ready-to-use pen
Extensively Studied Compound
Up to 22.5% body weight reduction observed in landmark SURMOUNT clinical trials
Once-Weekly Convenience
Single injection per week provides continuous dual-agonist action
Dual GIP + GLP-1 Action
Superior to GLP-1-only compounds like Semaglutide in head-to-head trials
La penna ORYN MediT è una penna per iniezione preriempita monouso contenente 40mg di Tirzepatide. Progettata per la somministrazione settimanale in protocolli di ricerca metabolica, con agonismo duale dei recettori GIP/GLP-1.
LEARN ABOUT THE MEDIT PEN PEN FORMAT →Complete dose-escalation protocol in a single, ready-to-use pen
Up to 22.5% body weight reduction observed in landmark SURMOUNT clinical trials
Single injection per week provides continuous dual-agonist action
Superior to GLP-1-only compounds like Semaglutide in head-to-head trials
Acqua batteriostatica, siringa, miscelazione precisa
Le tacche della siringa possono variare del 10-20%
Tappo in gomma perforato più volte
La potenza diminuisce dopo la ricostituzione
5-10 minuti per preparazione
Fiale, siringhe, acqua, aghi...
40mg pre-measured and ready to inject. No mixing, no measuring, no room for error. Pharmaceutical-standard dosing every time.
One injection per week. The MediT Pen's 5-day half-life means you inject once and the compound works continuously for days.
The same prefilled pen format used in billion-dollar clinical trials. Your research deserves the same quality of administration.
40mg provides up to 8-16 weeks of research depending on dose titration schedule, far more than standard 2.5-5mg clinical pens.
Tempo di Prep.
Precisione Dose
Sterilità
Stabilità
Remove pen cap and inspect solution (should be clear)
Attach the provided needle tip
Dial your weekly dose
Choose injection site (abdomen, thigh, or upper arm)
Inject subcutaneously and hold for 10 seconds
Dispose of needle and replace cap
Utilizzare sempre un ago sterile nuovo per ogni somministrazione. Smaltire gli aghi usati in un apposito contenitore per taglienti. Conservare la penna in frigorifero a 2-8°C.
MediT Pen
249,00 €
Glutathione
99,00 €
NAD+
189,00 €
Prezzo bundle — risparmia 53,70 € con questa combinazione
Dual GIP/GLP-1 Receptor Agonist - Prefilled Format
4,813.45 g/mol
Approximately 5 days
MediT Pen delivers Tirzepatide, a once-weekly dual incretin agonist. The 40mg prefilled format provides pharmaceutical-standard dosing for extended metabolic research protocols. Dual receptor activation is studied for its role in glycemic and metabolic pathway modulation.
Up to 22.5% body weight reduction over 72 weeks in adults with obesity, without diabetes.
Significant reduction in major cardiovascular events in patients with established cardiovascular disease.
Well-tolerated over 2+ years with sustained efficacy in weight management and glycemic control.
“The 40mg prefilled format is perfect for our 12-week dose-escalation protocols. No need to purchase new pens weekly like clinical formats.”
Dr. J. Braun
Metabolic Research, Zurich
“Indistinguishable from pharma-company prefilled pens in quality and ease of use. The 40mg supply streamlines our entire research workflow.”
Dr. M. Vasquez
Obesity Research, Barcelona
“40mg at this price point, with >99% purity and full documentation? Nothing else on the market comes close. Our go-to for all Tirzepatide research.”
Dr. F. Weber
Endocrine Lab, Munich
“The 40mg prefilled format is incredibly practical for our weekly research protocol. Quality matches pharmaceutical standards. The single-use design eliminates contamination risk entirely.”
Dr. C. Moreau
Lyon, France
“Once-weekly dosing in a prefilled pen is extremely convenient. Tirzepatide quality is confirmed by our lab. Only wish the price were slightly lower, but the quality and convenience make up for it.”
Oliver W.
Nottingham, UK
“We compared the MediT pen against the branded pharmaceutical product using identical analytical methods. The results were indistinguishable. This is genuinely pharmaceutical-grade tirzepatide in a well-designed delivery system.”
Dr. Anna M.
Warsaw, Poland
“The prefilled format means zero preparation time. Take it from the fridge, administer, dispose. Our weekly metabolic research protocol is now 15 minutes shorter thanks to the MediT pen. Quality is consistently excellent.”
Charlotte D.
Leeds, UK
“Delivery to Hamburg took three days. The MediT pen was packaged with premium cold-chain materials and the temperature indicator showed no deviation. Our HPLC analysis confirmed 99.2% purity. Excellent all round.”
Dr. Lukas R.
Hamburg, Germany
“The MediT pen is designed for weekly dosing and it fits our research schedule perfectly. The 40mg total gives us flexibility to adjust doses over a month-long study. Purity verified, delivery was prompt.”
Fiona M.
Glasgow, UK
“For our clinical research, cross-contamination between doses is a serious concern. The MediT single-use prefilled design completely eliminates that risk. Each pen is sterile and self-contained. Our compliance officer approved it immediately.”
Dr. S. Lombardi
Naples, Italy
“Ordered the MediT tirzepatide pen on a Tuesday afternoon and it was at our Manchester facility by Wednesday 10am. The quality matched the COA exactly. ORYN's UK delivery is remarkably fast.”
Thomas B.
Manchester, UK
“We sourced prefilled tirzepatide from two other European suppliers and ORYN's MediT pen was superior in every measurable way: purity, stability, packaging, and documentation. It is now our sole source.”
Dr. Katarina L.
Prague, Czech Republic
“Switching to MediT prefilled pens simplified our tirzepatide study protocol significantly. No more reconstitution, no more dose calculation errors, no more contamination risks. The research team unanimously prefers this format.”
Benjamin J.
Bristol, UK
“Getting research-grade tirzepatide delivered to France used to be a logistical challenge. ORYN has solved it. The MediT pen arrives in Paris within three days and the quality is always verified. A small premium over raw peptide, but the convenience is invaluable.”
Dr. M. Dupont
Paris, France
“Our metabolic research lab evaluated multiple tirzepatide products and the MediT pen won decisively. The prefilled format saves time, the purity is verified, and the documentation meets our institutional requirements.”
Amy S.
Cambridge, UK
“We tested the MediT tirzepatide using both GIP and GLP-1 receptor binding assays. Both showed expected activity levels consistent with properly folded tirzepatide. The prefilled pen maintained bioactivity across the full shelf life.”
Dr. Erik N.
Helsinki, Finland
“The MediT tirzepatide pen is genuinely outstanding. The only reason for three stars is the two-week shipping time to Brazil. The product itself was in perfect condition on arrival and our analysis confirmed full purity and activity.”
Diego R.
Curitiba, Brazil
“In 20 years of metabolic research, the MediT pen is the most practical tirzepatide delivery system I have encountered. The prefilled format, verified purity, and comprehensive documentation make it the gold standard for our field.”
Dr. Helen F.
Oxford, UK
“The MediT pen arrived in Antwerp in just three days. Packaging was excellent with proper cold-chain materials. Our lab confirmed the tirzepatide purity at 99.0% by HPLC. We have already placed our second order.”
Niels B.
Antwerp, Belgium
MediT is prefilled with 40mg for once-weekly use over 8-16 weeks. The Peptide Pen contains 10mg for daily micro-dosing over 30 days. MediT is designed for clinical-style weekly protocols.
Join 3,000+ researchers. Monthly SOPs, new peptide launches, and a WELCOME10 code for your first order.
NO SPAM · UNSUBSCRIBE ANYTIME
COA incluso con ogni ordine. Report specifici per lotto disponibili su richiesta.
See how ORYN pre-mixed peptide pens compare to traditional vials and other suppliers.
| Feature | ORYN Pens | Traditional Vials | Other Suppliers |
|---|---|---|---|
| Format | Pre-mixed pen | Lyophilised powder | Mixed |
| Purity | >99% verified | Variable (70-95%) | Claims vary |
| Dosing accuracy | <2% error | ~15% error | N/A |
| Reconstitution needed | No | Yes | Sometimes |
| Contamination risk | Sealed system | Multi-use vial | Varies |
| COA included | Every order | Rarely | Sometimes |
| GMP certified | Yes | Rarely | Some |
| EU customs-free | Yes | Often no | Varies |
Questo prodotto è destinato esclusivamente a scopi di laboratorio e ricerca. Non per consumo umano.
Sistema penna premium con dosaggio completamente regolabile. Prodotto GMP, purezza >99% garantita.
Più VendutoPeptide PenBPC-157Peptide di Ricerca per la Rigenerazione
Peptide PenTB-500Peptide di Ricerca per la Migrazione Cellulare
Peptide PenCJC-1295Peptide di Ricerca Secretagogo del GH
Peptide PenIpamorelinSecretagogo Selettivo del GH
Tirzepatide hit 20.9% weight loss vs semaglutide's 14.9% in trials. We compare mechanisms, side effects, and cost. Head-to-head data inside.
ARTICLETirzepatide, semaglutide, and 3 more metabolic peptides compared. Clinical trial data, dosing, side effects, and UK pricing from €169. Expert ranked.
ARTICLEWe tested 7 UK peptide pen brands on purity, price & delivery speed. See which scored highest from £99. Next-day UK delivery, >99% purity.
COMPARISONCompare tirzepatide and semaglutide for metabolic research. Dual vs single receptor, efficacy data, side effects, and pricing. Buy tirzepatide pens UK.
COMPARISONCompare ORYN Tirzepatide Pen (10mg daily) vs MediT Pen (40mg weekly). Dosing flexibility, convenience, cost, and which format suits your research. Buy UK.
ENCYCLOPEDIAGastric Pentadecapeptide. Molecular weight: 1419.53 Da. Explore mechanism of action, key studies, and research applications.
BUNDLEDual-format tirzepatide for comprehensive metabolic research
PROTOCOLResearch protocol for Tirzepatide peptide pen investigating dual GIP/GLP-1 receptor agonism. Explore metabolic mechanisms, dose titration schedules, and landmark clinical trial data.
FAQMediT Pen FAQ. Learn about ORYN's prefilled weekly Tirzepatide 40mg injection pen, dosing protocols, storage, and metabolic research applications.
CATEGORYResearch-grade weight loss peptide pens. Tirzepatide dual GIP/GLP-1 agonist for metabolic research. Pre-mixed pens, >99% purity, next-day UK delivery.
CATEGORYResearch-grade peptides for body composition. Tirzepatide, CJC-1295, Ipamorelin, and MediT for fat loss and lean mass. >99% purity, UK delivery.